Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
ACS Medicinal Chemistry Letters
|
July 18, 2019
Creating a Virtual Assistant for Medicinal Chemistry
Lewis R Vidler, Matthew P Baumgartner
Journal of Medicinal Chemistry
|
July 14, 2012
Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites
Lewis R Vidler, Nathan Brown, Stefan Knapp, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 16, 2016
Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia
Simone de Jong, Lewis R Vidler, Younes Mokrab, et al.
ACS Medicinal Chemistry Letters
|
August 22, 2018
Investigating the Behavior of Published PAINS Alerts Using a Pharmaceutical Company Data Set
Lewis R Vidler, Ian A Watson, Brandon J Margolis, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Beyond PAINs: Chemotype Sensitivity of Protein Methyltransferases in Screens
Cen Gao, Brandon J Margolis, John M Strelow, et al.
Journal of Medicinal Chemistry
|
October 5, 2013
Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening
Lewis R Vidler, Panagis Filippakopoulos, Oleg Fedorov, et al.
Scientific Reports
|
September 30, 2020
Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approaches
John F Darby, Lewis R Vidler, Peter J Simpson, et al.
Dalton Transactions (Cambridge, England : 2003)
|
August 6, 2009
Changing the local coordination environment in mono- and bi- nuclear lanthanide complexes through "click" chemistry
Maite Jauregui, William S Perry, Clémence Allain, et al.
ACS Medicinal Chemistry Letters
|
February 18, 2022
A Comparative Assessment Study of Known Small-molecule GPVI Modulators
Holly Foster, Clare Wilson, Julia S Gauer, et al.
ACS Medicinal Chemistry Letters
|
November 17, 2023
Design of Novel Series of Antimalarial PMX Inhibitors with Increased Half-Life via Molecular Property Optimization
Komei Sakata, Martin A Lowe, Mengyang Xuan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
ACS Medicinal Chemistry Letters
|
July 18, 2019
Creating a Virtual Assistant for Medicinal Chemistry
Lewis R Vidler, Matthew P Baumgartner
Journal of Medicinal Chemistry
|
July 14, 2012
Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites
Lewis R Vidler, Nathan Brown, Stefan Knapp, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 16, 2016
Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia
Simone de Jong, Lewis R Vidler, Younes Mokrab, et al.
ACS Medicinal Chemistry Letters
|
August 22, 2018
Investigating the Behavior of Published PAINS Alerts Using a Pharmaceutical Company Data Set
Lewis R Vidler, Ian A Watson, Brandon J Margolis, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Beyond PAINs: Chemotype Sensitivity of Protein Methyltransferases in Screens
Cen Gao, Brandon J Margolis, John M Strelow, et al.
Journal of Medicinal Chemistry
|
October 5, 2013
Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening
Lewis R Vidler, Panagis Filippakopoulos, Oleg Fedorov, et al.
Scientific Reports
|
September 30, 2020
Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approaches
John F Darby, Lewis R Vidler, Peter J Simpson, et al.
Dalton Transactions (Cambridge, England : 2003)
|
August 6, 2009
Changing the local coordination environment in mono- and bi- nuclear lanthanide complexes through "click" chemistry
Maite Jauregui, William S Perry, Clémence Allain, et al.
ACS Medicinal Chemistry Letters
|
February 18, 2022
A Comparative Assessment Study of Known Small-molecule GPVI Modulators
Holly Foster, Clare Wilson, Julia S Gauer, et al.
ACS Medicinal Chemistry Letters
|
November 17, 2023
Design of Novel Series of Antimalarial PMX Inhibitors with Increased Half-Life via Molecular Property Optimization
Komei Sakata, Martin A Lowe, Mengyang Xuan, et al.
Page
of 2